Literature DB >> 16941225

WWOX protein expression in normal human tissues.

Maria I Nunez1, John Ludes-Meyers, C Marcelo Aldaz.   

Abstract

WWOX is a putative tumor suppressor gene that spans approximately a 1 Mb genomic region and is the site for the second most common chromosomal fragile site, FRA16D at 16q23. Various studies have focused on the expression of WWOX in human cancer mostly at the RNA level, but little is known about the normal pattern of WWOX protein expression in non-neoplastic tissues. In this study, a comprehensive analysis of WWOX protein expression in normal tissues was performed by means of immunohistochemistry utilizing a very specific anti-WWOX polyclonal antibody. We analyzed tissue cores of human samples representing more than 30 organs, using various tissue microarray (TMA) slides. Due to the potential role of WWOX in sex-steroid metabolism, whole sections from hormonally regulated organs like breast, ovaries, testes and prostate were also analyzed. The results from our study indicate that WWOX is preferentially highly expressed in secretory epithelial cells of reproductive, endocrine and exocrine organs, as well as in ductal epithelial cells from specific segments of the urinary system. Interestingly, we also observed significant WWOX protein expression in various cell types of neural origin including neurons, ependymal cells and astrocytes. No expression of WWOX was detected in adipose, connective, and lymphoid tissues, myelinized structures and blood vessels. By better defining the topographic distribution of WWOX in normal tissues this study provides some insight on the potential physiological role of this novel protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941225      PMCID: PMC4144810          DOI: 10.1007/s10735-006-9046-5

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  25 in total

1.  Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.

Authors:  Flávio J Pimenta; Dawidson A Gomes; Paolla F Perdigão; Alvimar A Barbosa; Marco A Romano-Silva; Marcus V Gomez; C Marcelo Aldaz; Luiz De Marco; Ricardo S Gomez
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

2.  PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction.

Authors:  Changjiang Jin; Ling Ge; Xia Ding; Yong Chen; Hongling Zhu; Tarsha Ward; Fang Wu; Xinwang Cao; Qichen Wang; Xuebiao Yao
Journal:  Biochem Biophys Res Commun       Date:  2006-01-19       Impact factor: 3.575

3.  WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.

Authors:  E Płuciennik; R Kusińska; P Potemski; R Kubiak; R Kordek; A K Bednarek
Journal:  Eur J Surg Oncol       Date:  2005-12-15       Impact factor: 4.424

4.  A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.

Authors:  A J Paige; K J Taylor; A Stewart; J G Sgouros; H Gabra; G C Sellar; J F Smyth; D J Porteous; J E Watson
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

Review 5.  Common chromosomal fragile sites and cancer: focus on FRA16D.

Authors:  Louise V O'Keefe; Robert I Richards
Journal:  Cancer Lett       Date:  2005-10-20       Impact factor: 8.679

6.  The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.

Authors:  K A Krummel; L R Roberts; M Kawakami; T W Glover; D I Smith
Journal:  Genomics       Date:  2000-10-01       Impact factor: 5.736

Review 7.  Roles of FHIT and WWOX fragile genes in cancer.

Authors:  Dimitrios Iliopoulos; Gulnur Guler; Shuang-Yin Han; Teresa Druck; Michelle Ottey; Kelly A McCorkell; Kay Huebner
Journal:  Cancer Lett       Date:  2005-10-12       Impact factor: 8.679

Review 8.  Common fragile sites, extremely large genes, neural development and cancer.

Authors:  David I Smith; Yu Zhu; Sarah McAvoy; Robert Kuhn
Journal:  Cancer Lett       Date:  2005-10-10       Impact factor: 8.679

9.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.

Authors:  Rami I Aqeilan; Valentina Donati; Alexey Palamarchuk; Francesco Trapasso; Mohamed Kaou; Yuri Pekarsky; Marius Sudol; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

10.  WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.

Authors:  María I Nunez; Daniel G Rosen; John H Ludes-Meyers; Martín C Abba; Hyunsuk Kil; Robert Page; Andres J P Klein-Szanto; Andrew K Godwin; Jinsong Liu; Gordon B Mills; C Marcelo Aldaz
Journal:  BMC Cancer       Date:  2005-06-27       Impact factor: 4.430

View more
  37 in total

1.  A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development.

Authors:  Stefan White; Jacqueline Hewitt; Erin Turbitt; Yvonne van der Zwan; Remko Hersmus; Stenvert Drop; Peter Koopman; Vincent Harley; Martine Cools; Leendert Looijenga; Andrew Sinclair
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling.

Authors:  Juan Li; Xuefei Feng; Canyu Li; Jie Liu; Pingping Li; Ruiqi Wang; He Chen; Peijun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-02

3.  Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.

Authors:  Sara Del Mare; Kyle C Kurek; Gary S Stein; Jane B Lian; Rami I Aqeilan
Journal:  Am J Cancer Res       Date:  2011-04-03       Impact factor: 6.166

4.  Novel mutations in WWOX, RARS2, and C10orf2 genes in consanguineous Arab families with intellectual disability.

Authors:  Asem M Alkhateeb; Samah K Aburahma; Wesal Habbab; I Richard Thompson
Journal:  Metab Brain Dis       Date:  2016-04-28       Impact factor: 3.584

Review 5.  WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.

Authors:  C Marcelo Aldaz; Brent W Ferguson; Martin C Abba
Journal:  Biochim Biophys Acta       Date:  2014-06-14

6.  WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Maria I Nuñez; Claudio J Conti; Jan Parker-Thornburg; Mark T Bedford; C Marcelo Aldaz
Journal:  Genes Chromosomes Cancer       Date:  2007-12       Impact factor: 5.006

7.  WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels.

Authors:  Jenny C Lee; Daphna Weissglas-Volkov; Mira Kyttälä; Zari Dastani; Rita M Cantor; Eric M Sobel; Christopher L Plaisier; James C Engert; Marleen M J van Greevenbroek; John P Kane; Mary J Malloy; Clive R Pullinger; Adriana Huertas-Vazquez; Carlos A Aguilar-Salinas; Teresa Tusie-Luna; Tjerk W A de Bruin; Bradley E Aouizerat; Carla C J van der Kallen; Carlo M Croce; Rami I Aqeilan; Michel Marcil; Jorma S A Viikari; Terho Lehtimäki; Olli T Raitakari; Johanna Kuusisto; Markku Laakso; Marja-Riitta Taskinen; Jacques Genest; Päivi Pajukanta
Journal:  Am J Hum Genet       Date:  2008-08       Impact factor: 11.025

8.  WWOX gene is associated with HDL cholesterol and triglyceride levels.

Authors:  María E Sáez; Antonio González-Pérez; María T Martínez-Larrad; Javier Gayán; Luis M Real; Manuel Serrano-Ríos; Agustín Ruiz
Journal:  BMC Med Genet       Date:  2010-10-14       Impact factor: 2.103

9.  The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation.

Authors:  Martial Mallaret; Matthis Synofzik; Jaeho Lee; Cari A Sagum; Muhammad Mahajnah; Rajech Sharkia; Nathalie Drouot; Mathilde Renaud; Fabrice A C Klein; Mathieu Anheim; Christine Tranchant; Cyril Mignot; Jean-Louis Mandel; Mark Bedford; Peter Bauer; Mustafa A Salih; Rebecca Schüle; Ludger Schöls; C Marcelo Aldaz; Michel Koenig
Journal:  Brain       Date:  2013-12-24       Impact factor: 13.501

10.  Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene.

Authors:  John H Ludes-Meyers; Hyunsuk Kil; Jan Parker-Thornburg; Donna F Kusewitt; Mark T Bedford; C Marcelo Aldaz
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.